News
GNTA
1.300
0.00%
0.000
Weekly Report: what happened at GNTA last week (0803-0807)?
Weekly Report · 3d ago
ADRs Advance; Arm Holdings PLC Climbs 17%
Dow Jones · 08/04 20:31
Weekly Report: what happened at GNTA last week (0727-0731)?
Weekly Report · 08/03 10:26
Genenta Science Shareholders Approve Major Capital Authorization and Reverse Split Plan
TipRanks · 07/31 20:28
Weekly Report: what happened at GNTA last week (0720-0724)?
Weekly Report · 07/27 10:31
Sophia unveils Roman robotic arm to inspect nuclear fusion machine operations
TipRanks · 07/23 09:40
Genenta Science reports FY results
Seeking Alpha · 07/22 12:49
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
Barchart · 07/22 03:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 07/20 12:05
Weekly Report: what happened at GNTA last week (0713-0717)?
Weekly Report · 07/20 10:27
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 07/17 12:05
Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling
TipRanks · 07/14 20:28
Weekly Report: what happened at GNTA last week (0706-0710)?
Weekly Report · 07/13 10:29
Weekly Report: what happened at GNTA last week (0629-0703)?
Weekly Report · 07/06 10:34
Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal
TipRanks · 07/01 20:27
Weekly Report: what happened at GNTA last week (0622-0626)?
Weekly Report · 06/29 10:28
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands
TipRanks · 06/26 20:42
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026
TipRanks · 06/24 13:27
Weekly Report: what happened at GNTA last week (0615-0619)?
Weekly Report · 06/22 10:39
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split
TipRanks · 06/17 13:30
More
Webull provides a variety of real-time GNTA stock news. You can receive the latest news about Genenta Science Spa through multiple platforms. This information may help you make smarter investment decisions.
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.